Beta Drugs Shareholding Pattern

As of Dec 2025, Beta Drugs (BETA) promoter holding 64.90%, FII 1.14%, DII 1.89%, public 21.78%, total shareholders 3,694. For live price, key ratios and the full company profile, see BETA stock live price.

Promoter Holding 64.90%
FII Holding 1.14%
DII Holding 1.89%
Public Holding 21.78%
Total Shareholders 3,694
As of Dec 2025

BETA Recent Shareholding Changes — Promoter, FII & DII

Beta Drugs promoter, FII and DII holding change from Nov 2025 to Dec 2025 — promoter -1.83%, FII +1.14%, DII +1.89%. Examine Beta Drugs quarterly earnings for recent quarterly revenue, profit and EPS trends.

Promoter Holding Change
Nov 2025 to Dec 2025
-1.83%
FII Holding Change
Nov 2025 to Dec 2025
+1.14%
DII Holding Change
Nov 2025 to Dec 2025
+1.89%
Public Holding Change
Nov 2025 to Dec 2025
No Change

Beta Drugs Quarterly Shareholding Trend — Promoter, FII, DII & Public

BETA promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Review BETA P/E ratio to evaluate earnings-based valuation against sector peers.

Promoter
FII
DII
Public
Government

BETA Shareholding Pattern Data — Quarterly History

Beta Drugs quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 64.90% 1.14% 1.89% 0.00% 21.78% 10.29% 100.00% 3,694
Nov 2025 66.73% 0.00% 0.00% 0.00% 21.78% 11.49% 100.00% 3,003
Sept 2025 66.73% 0.00% 0.00% 0.00% 21.81% 11.45% 99.99% 3,184
Jun 2025 66.73% 0.00% 0.00% 0.00% 21.75% 11.51% 99.99% 3,139
Mar 2025 66.73% 0.00% 0.00% 0.00% 21.81% 11.45% 99.99% 3,045
Dec 2024 66.73% 0.00% 0.00% 0.00% 21.60% 11.66% 99.99% 2,882
Nov 2024 66.73% 0.00% 0.00% 0.00% 21.63% 11.64% 100.00% 2,793
Sept 2024 66.73% 0.00% 0.00% 0.00% 21.70% 11.56% 99.99% 2,567
Jun 2024 66.73% 0.00% 0.00% 0.00% 21.96% 11.31% 100.00% 2,323
Mar 2024 66.73% 0.00% 0.00% 0.00% 22.35% 10.91% 99.99% 2,116
Dec 2023 66.73% 0.32% 0.02% 0.00% 22.33% 10.60% 100.00% 1,928
Sept 2023 66.73% 0.00% 0.00% 0.00% 22.37% 10.90% 100.00% 1,722
Jun 2023 66.73% 0.00% 0.00% 0.00% 22.24% 11.03% 100.00% 1,451
Mar 2023 66.73% 0.00% 0.00% 0.00% 22.52% 10.75% 100.00% 1,424
Dec 2022 66.71% 0.00% 0.00% 0.00% 22.60% 10.69% 100.00% 1,407
Sept 2022 66.71% 0.00% 0.00% 0.00% 22.61% 10.68% 100.00% 1,296
Jun 2022 66.71% 0.00% 0.00% 0.00% 22.59% 10.70% 100.00% 762
Mar 2022 66.71% 0.00% 0.00% 0.00% 22.86% 10.43% 100.00% 675
Dec 2021 66.71% 0.00% 0.00% 0.00% 22.86% 10.43% 100.00% 542
Sept 2021 66.68% 0.00% 0.00% 0.00% 22.72% 10.60% 100.00% 507
Jun 2021 66.68% 0.00% 0.00% 0.00% 21.88% 11.44% 100.00% 540
Mar 2021 66.68% 0.00% 0.00% 0.00% 21.63% 11.68% 99.99% 0
Sept 2017 93.78% 0.00% 0.00% 0.00% 0.00% 6.22% 100.00% 0
Aug 2017 93.78% 0.00% 0.00% 0.00% 0.00% 6.22% 100.00% 0
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 64.90% 1.14% 1.89% 0.00% 21.78% 10.29% 100.00% 3,694
Nov 2025 66.73% 0.00% 0.00% 0.00% 21.78% 11.49% 100.00% 3,003
Sept 2025 66.73% 0.00% 0.00% 0.00% 21.81% 11.45% 99.99% 3,184
Jun 2025 66.73% 0.00% 0.00% 0.00% 21.75% 11.51% 99.99% 3,139
Mar 2025 66.73% 0.00% 0.00% 0.00% 21.81% 11.45% 99.99% 3,045
Dec 2024 66.73% 0.00% 0.00% 0.00% 21.60% 11.66% 99.99% 2,882
Nov 2024 66.73% 0.00% 0.00% 0.00% 21.63% 11.64% 100.00% 2,793
Sept 2024 66.73% 0.00% 0.00% 0.00% 21.70% 11.56% 99.99% 2,567
Jun 2024 66.73% 0.00% 0.00% 0.00% 21.96% 11.31% 100.00% 2,323
Mar 2024 66.73% 0.00% 0.00% 0.00% 22.35% 10.91% 99.99% 2,116
Dec 2023 66.73% 0.32% 0.02% 0.00% 22.33% 10.60% 100.00% 1,928
Sept 2023 66.73% 0.00% 0.00% 0.00% 22.37% 10.90% 100.00% 1,722
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 64.90% 1.14% 1.89% 0.00% 21.78% 10.29% 100.00% 3,694
Dec 2024 66.73% 0.00% 0.00% 0.00% 21.60% 11.66% 99.99% 2,882
Dec 2023 66.73% 0.32% 0.02% 0.00% 22.33% 10.60% 100.00% 1,928
Dec 2022 66.71% 0.00% 0.00% 0.00% 22.60% 10.69% 100.00% 1,407
Dec 2021 66.71% 0.00% 0.00% 0.00% 22.86% 10.43% 100.00% 542